Compare TRVI & BHE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TRVI | BHE |
|---|---|---|
| Founded | 2011 | 1979 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Electrical Products |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.4B | 1.7B |
| IPO Year | 2019 | 1990 |
| Metric | TRVI | BHE |
|---|---|---|
| Price | $12.62 | $47.40 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 11 | 2 |
| Target Price | $20.59 | ★ $46.50 |
| AVG Volume (30 Days) | ★ 2.4M | 263.0K |
| Earning Date | 11-13-2025 | 01-28-2026 |
| Dividend Yield | N/A | ★ 1.43% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 1.02 |
| Revenue | N/A | ★ $2,611,664,000.00 |
| Revenue This Year | N/A | $0.82 |
| Revenue Next Year | N/A | $5.19 |
| P/E Ratio | ★ N/A | $46.89 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $3.43 | $30.73 |
| 52 Week High | $14.39 | $50.26 |
| Indicator | TRVI | BHE |
|---|---|---|
| Relative Strength Index (RSI) | 52.54 | 61.30 |
| Support Level | $12.92 | $46.69 |
| Resistance Level | $14.39 | $49.89 |
| Average True Range (ATR) | 0.87 | 1.29 |
| MACD | -0.09 | 0.15 |
| Stochastic Oscillator | 43.71 | 56.35 |
Trevi Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of the investigational therapy Haduvio (oral nalbuphine ER) for the treatment of chronic cough in adults with idiopathic pulmonary fibrosis, or IPF, and other chronic cough indications, and for the treatment of prurigo nodularis. Haduvio is an oral extended-release formulation of nalbuphine.
Benchmark Electronics Inc is engaged in product designing, engineering services, technology solutions, and manufacturing services (electronic manufacturing services (EMS) and precision technology services). It serves various industries, including aerospace & defense (A&D), medical technologies, complex industrials, semiconductor capital equipment, next-generation telecommunications, and high-end computing. Its geographical segments are the Americas, Asia and Europe of which key revenue is derived from the Americas.